Annual Cash & Cash Equivalents
$17.80 M
-$16.93 M-48.75%
December 31, 2023
Summary
- As of February 8, 2025, TSBX annual cash & cash equivalents is $17.80 million, with the most recent change of -$16.93 million (-48.75%) on December 31, 2023.
- During the last 3 years, TSBX annual cash & cash equivalents has fallen by -$105.58 million (-85.57%).
- TSBX annual cash & cash equivalents is now -85.57% below its all-time high of $123.38 million, reached on December 31, 2021.
Performance
TSBX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$24.13 M
+$6.73 M+38.69%
September 30, 2024
Summary
- As of February 8, 2025, TSBX quarterly cash and cash equivalents is $24.13 million, with the most recent change of +$6.73 million (+38.69%) on September 30, 2024.
- Over the past year, TSBX quarterly cash and cash equivalents has dropped by -$14.64 million (-37.76%).
- TSBX quarterly cash and cash equivalents is now -37.76% below its all-time high of $38.78 million, reached on September 30, 2023.
Performance
TSBX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TSBX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.8% | -37.8% |
| 3 y3 years | -85.6% | +12.1% |
| 5 y5 years | -85.6% | +12.1% |
TSBX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -85.6% | at low | -37.8% | +67.2% |
| 5 y | 5-year | -85.6% | at low | -37.8% | +67.2% |
| alltime | all time | -85.6% | at low | -37.8% | +67.2% |
Turnstone Biologics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $24.13 M(+38.7%) |
| Jun 2024 | - | $17.40 M(+20.6%) |
| Mar 2024 | - | $14.43 M(-18.9%) |
| Dec 2023 | $17.80 M | $17.80 M(-54.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $38.78 M(+80.1%) |
| Jun 2023 | - | $21.53 M(-35.8%) |
| Mar 2023 | - | $33.51 M(-3.5%) |
| Dec 2022 | $34.73 M(-71.9%) | $34.73 M |
| Dec 2021 | $123.38 M | - |
FAQ
- What is Turnstone Biologics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Turnstone Biologics?
- What is Turnstone Biologics annual cash & cash equivalents year-on-year change?
- What is Turnstone Biologics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Turnstone Biologics?
- What is Turnstone Biologics quarterly cash and cash equivalents year-on-year change?
What is Turnstone Biologics annual cash & cash equivalents?
The current annual cash & cash equivalents of TSBX is $17.80 M
What is the all time high annual cash & cash equivalents for Turnstone Biologics?
Turnstone Biologics all-time high annual cash & cash equivalents is $123.38 M
What is Turnstone Biologics annual cash & cash equivalents year-on-year change?
Over the past year, TSBX annual cash & cash equivalents has changed by -$16.93 M (-48.75%)
What is Turnstone Biologics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TSBX is $24.13 M
What is the all time high quarterly cash and cash equivalents for Turnstone Biologics?
Turnstone Biologics all-time high quarterly cash and cash equivalents is $38.78 M
What is Turnstone Biologics quarterly cash and cash equivalents year-on-year change?
Over the past year, TSBX quarterly cash and cash equivalents has changed by -$14.64 M (-37.76%)